125 related articles for article (PubMed ID: 17251216)
1. Renal protection by N-acetylcysteine.
Shehabi Y
Br J Anaesth; 2007 Feb; 98(2):270; author reply 270-1. PubMed ID: 17251216
[No Abstract] [Full Text] [Related]
2. Protection from contrast-induced nephropathy: is the answer in?
Dean LS
Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
[No Abstract] [Full Text] [Related]
3. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure.
Morgan PG; Georghiou M; Flynn F; Jaggar S
Br J Anaesth; 2007 Jul; 99(1):143; author reply 143-4. PubMed ID: 17573400
[No Abstract] [Full Text] [Related]
4. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
5. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
Ristikankare A; Kuitunen T; Kuitunen A; Uotila L; Vento A; Suojaranta-Ylinen R; Salmenperä M; Pöyhiä R
Br J Anaesth; 2006 Nov; 97(5):611-6. PubMed ID: 16914459
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury.
Kizilgun M; Poyrazoglu Y; Oztas Y; Yaman H; Cakir E; Cayci T; Akgul OE; Kurt YG; Yaren H; Kunak ZI; Macit E; Ozkan E; Taslipinar MY; Turker T; Ozcan A
Ren Fail; 2011; 33(5):512-7. PubMed ID: 21545313
[TBL] [Abstract][Full Text] [Related]
7. Of hypes and hopes: N-acetylcysteine and cystatin C.
Schultz MJ; Royakkers AA; Bouman CS
AJR Am J Roentgenol; 2008 Mar; 190(3):W224; author reply W225. PubMed ID: 18287418
[No Abstract] [Full Text] [Related]
8. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
Moore NN; Lapsley M; Norden AG; Firth JD; Gaunt ME; Varty K; Boyle JR
J Endovasc Ther; 2006 Oct; 13(5):660-6. PubMed ID: 17042662
[TBL] [Abstract][Full Text] [Related]
9. How to protect from contrast media-induced nephropathy?
Scheller B
Clin Res Cardiol; 2007 Mar; 96(3):125-9. PubMed ID: 17294353
[No Abstract] [Full Text] [Related]
10. [Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
Rizzato G
Radiol Med; 2001 Apr; 101(4):287-9. PubMed ID: 11398061
[No Abstract] [Full Text] [Related]
11. Are we still wondering or wandering in the dark?
Cattano D
Intern Emerg Med; 2011 Dec; 6(6):485-6. PubMed ID: 21416287
[No Abstract] [Full Text] [Related]
12. In search of an algorithm to prevent acute kidney injury.
Dauerman HL
JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
[No Abstract] [Full Text] [Related]
13. [Value of N-acetylcysteine to prevent nephrotoxicity from iodinated contrast agents].
Deray G
J Radiol; 2004 Jun; 85(6 Pt 1):725-7. PubMed ID: 15243372
[TBL] [Abstract][Full Text] [Related]
14. Effects of dexpanthenol and N-acetylcysteine pretreatment in rats before renal ischemia/reperfusion injury.
Sen H; Deniz S; Yedekci AE; Inangil G; Muftuoglu T; Haholu A; Ozkan S
Ren Fail; 2014 Nov; 36(10):1570-4. PubMed ID: 25156619
[TBL] [Abstract][Full Text] [Related]
15. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
16. N-acetylcysteine: multiple organ saver during cardiac surgery?
Bouman CC; Schultz MJ
Crit Care Med; 2008 Jan; 36(1):338-40. PubMed ID: 18158446
[No Abstract] [Full Text] [Related]
17. Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.
Safirstein R; Andrade L; Vieira JM
N Engl J Med; 2000 Jul; 343(3):210-2. PubMed ID: 10900284
[No Abstract] [Full Text] [Related]
18. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
19. The effects of N-acetylcysteine and ozone therapy on oxidative stress and inflammation in acetaminophen-induced nephrotoxicity model.
Ucar F; Taslipinar MY; Alp BF; Aydin I; Aydin FN; Agilli M; Toygar M; Ozkan E; Macit E; Oztosun M; Cayci T; Ozcan A
Ren Fail; 2013; 35(5):640-7. PubMed ID: 23560513
[TBL] [Abstract][Full Text] [Related]
20. Pseudoporphyria induced by dialysis treated with oral N-acetylcysteine.
Guiotoku MM; Pereira Fde P; Miot HA; Marques ME
An Bras Dermatol; 2011; 86(2):383-5. PubMed ID: 21603831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
